$595 Million is the total value of ORIX CORP's 1 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q3 2018 |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ORMAT TECHNOLOGIES INC | 27 | Q2 2024 | 100.0% |
View ORIX CORP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
ORMAT TECHNOLOGIES, INC. | November 29, 2022 | 6,676,077 | 11.9% |
Sucampo Pharmaceuticals, Inc.Sold out | June 18, 2015 | 0 | 0.0% |
View ORIX CORP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
6-K | 2024-09-11 |
424B2 | 2024-09-04 |
6-K | 2024-09-04 |
FWP | 2024-09-04 |
424B5 | 2024-09-03 |
N-PX | 2024-08-29 |
13F-HR | 2024-08-13 |
6-K | 2024-08-05 |
6-K | 2024-07-03 |
6-K | 2024-06-28 |
View ORIX CORP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (20-F)
- Quarterly reports (6-K)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.